Skip to main content
Top
Published in: AIDS and Behavior 4/2010

01-08-2010 | Original Paper

Lack of Association between Retrospectively Collected Pharmacy Refill Data and Electronic Drug Monitoring of Antiretroviral Adherence

Authors: Trisha Acri, Thomas R. TenHave, Jennifer C. Chapman, Hillary R. Bogner, Robert Gross

Published in: AIDS and Behavior | Issue 4/2010

Login to get access

Abstract

Antiretroviral medication refill adherence has not been compared directly to electronic drug monitoring (EDM) in any identifiable published study. We retrospectively studied adults with undetectable HIV titers on highly active antiretroviral therapy. We used Pearson correlation coefficients and receiver operating characteristic curves to relate the two adherence measures, and we used the Wilcoxon rank-sum test to assess the relation between adherence and viral load. In sixty-five subjects, the majority of whom were African American and male with median age of 44 years, pharmacy refill adherence was difficult to collect retrospectively, was not significantly correlated with EDM adherence, and was not significantly related to viral load. Ninety-day supply pharmacy refill adherence correctly classified 95% EDM adherence maximally at 94 days between refills, and the measure was most sensitive for non-adherence at <90 days. Reassessment of the relation between pharmacy refill data and EDM would be warranted when pharmacy refill data is collected as soon as feasible from sources with complete data capture.
Literature
go back to reference Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (London, England), 14, 357–366. doi:10.1097/00002030-200003100-00008. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (London, England), 14, 357–366. doi:10.​1097/​00002030-200003100-00008.
go back to reference Bangsberg, D., Hecht, F., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., et al. (2001b). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435–442.PubMed Bangsberg, D., Hecht, F., Clague, H., Charlebois, E. D., Ciccarone, D., Chesney, M., et al. (2001b). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435–442.PubMed
go back to reference Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., et al. (2001a). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (London, England), 11, 1181–1183. doi:10.1097/00002030-200106150-00015. Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., et al. (2001a). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (London, England), 11, 1181–1183. doi:10.​1097/​00002030-200106150-00015.
go back to reference Centers for Disease Control and Prevention. (2006). Epidemiology of HIV/AIDS—United States, 1981–2005. MMWR. Morbidity and Mortality Weekly Report, 55, 589–592. Centers for Disease Control and Prevention. (2006). Epidemiology of HIV/AIDS—United States, 1981–2005. MMWR. Morbidity and Mortality Weekly Report, 55, 589–592.
go back to reference Choo, P. W., Rand, C. S., Inui, T. S., Lee, M. L., Cain, E., Cordeiro-Breault, M., et al. (1999). Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Medical Care, 37, 846–857. doi:10.1097/00005650-199909000-00002.CrossRefPubMed Choo, P. W., Rand, C. S., Inui, T. S., Lee, M. L., Cain, E., Cordeiro-Breault, M., et al. (1999). Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Medical Care, 37, 846–857. doi:10.​1097/​00005650-199909000-00002.CrossRefPubMed
go back to reference Deyo, R. A., Inui, T. S., & Sullivan, B. (1981). Noncompliance with arthritis drugs: Magnitude, correlates, and clinical implications. The Journal of Rheumatology, 8, 931–936.PubMed Deyo, R. A., Inui, T. S., & Sullivan, B. (1981). Noncompliance with arthritis drugs: Magnitude, correlates, and clinical implications. The Journal of Rheumatology, 8, 931–936.PubMed
go back to reference Diggle, P. J., Liang, K.-Y., & Zeger, S. L. (1994). Analysis of longitudinal data. New York: Oxford University Press. Diggle, P. J., Liang, K.-Y., & Zeger, S. L. (1994). Analysis of longitudinal data. New York: Oxford University Press.
go back to reference Garcia de Olalla, P., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30, 105–110. doi:10.1097/00126334-200205010-00014.CrossRefPubMed Garcia de Olalla, P., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30, 105–110. doi:10.​1097/​00126334-200205010-00014.CrossRefPubMed
go back to reference Graham, J., Bennett, I. M., Holmes, W. C., & Gross, R. (2007). Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS and Behavior, 11, 385–392. doi:10.1007/s10461-006-9164-9.CrossRefPubMed Graham, J., Bennett, I. M., Holmes, W. C., & Gross, R. (2007). Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS and Behavior, 11, 385–392. doi:10.​1007/​s10461-006-9164-9.CrossRefPubMed
go back to reference Gross, R., Bilker, W. B., Friedman, H. M., Coyne, J. C., & Strom, B. L. (2002). Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS (London, England), 16, 1835–1837. doi:10.1097/00002030-200209060-00021. Gross, R., Bilker, W. B., Friedman, H. M., Coyne, J. C., & Strom, B. L. (2002). Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS (London, England), 16, 1835–1837. doi:10.​1097/​00002030-200209060-00021.
go back to reference Gross, R., Bilker, W. B., Friedman, H. M., & Strom, B. L. (2001). Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS (London, England), 15, 2109–2117. doi:10.1097/00002030-200111090-00006. Gross, R., Bilker, W. B., Friedman, H. M., & Strom, B. L. (2001). Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS (London, England), 15, 2109–2117. doi:10.​1097/​00002030-200111090-00006.
go back to reference Gross, R., Bilker, W. B., Wang, H., & Chapman, J. (2008). How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? HIV Clinical Trials, 9, 202–206. doi:10.1310/hct0903-202.CrossRefPubMed Gross, R., Bilker, W. B., Wang, H., & Chapman, J. (2008). How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? HIV Clinical Trials, 9, 202–206. doi:10.​1310/​hct0903-202.CrossRefPubMed
go back to reference Gross, R., Yip, B., Re, V. L., Wood, E., Alexander, C. S., Harrigan, P. R., et al. (2006). A simple, dynamic measure of antiretroviral therapy predicts failure to maintain HIV-1 suppression. The Journal of Infectious Diseases, 194, 1108–1114. doi:10.1086/507680.CrossRefPubMed Gross, R., Yip, B., Re, V. L., Wood, E., Alexander, C. S., Harrigan, P. R., et al. (2006). A simple, dynamic measure of antiretroviral therapy predicts failure to maintain HIV-1 suppression. The Journal of Infectious Diseases, 194, 1108–1114. doi:10.​1086/​507680.CrossRefPubMed
go back to reference Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29–36.PubMed Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29–36.PubMed
go back to reference Holmes, W. C., Bilker, W. B., Wang, H., Chapman, J., & Gross, R. (2007). HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. Journal of Acquired Immune Deficiency Syndromes, 46, 323–327.CrossRefPubMed Holmes, W. C., Bilker, W. B., Wang, H., Chapman, J., & Gross, R. (2007). HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time. Journal of Acquired Immune Deficiency Syndromes, 46, 323–327.CrossRefPubMed
go back to reference Kalichman, S. C., Amaral, C. M., Stearns, H., White, D., Flanagan, J., Pope, H., et al. (2007). Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. Journal of General Internal Medicine, 22, 1003–1006. doi:10.1007/s11606-007-0171-y.CrossRefPubMed Kalichman, S. C., Amaral, C. M., Stearns, H., White, D., Flanagan, J., Pope, H., et al. (2007). Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. Journal of General Internal Medicine, 22, 1003–1006. doi:10.​1007/​s11606-007-0171-y.CrossRefPubMed
go back to reference Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.PubMed Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.PubMed
go back to reference McNabb, J. J., Nicolau, D. P., Stoner, J. A., & Ross, J. (2003). Patterns of adherence to antiretroviral medications: The value of electronic monitoring. AIDS (London, England), 17, 1763–1767. doi:10.1097/00002030-200308150-00005. McNabb, J. J., Nicolau, D. P., Stoner, J. A., & Ross, J. (2003). Patterns of adherence to antiretroviral medications: The value of electronic monitoring. AIDS (London, England), 17, 1763–1767. doi:10.​1097/​00002030-200308150-00005.
go back to reference Rudd, P., Ahmed, S., Zachary, V., Barton, C., & Bonduelle, D. (1990). Improved compliance measures: Applications in an ambulatory hypertensive drug trial. Clinical Pharmacology and Therapeutics, 48, 676–685.CrossRefPubMed Rudd, P., Ahmed, S., Zachary, V., Barton, C., & Bonduelle, D. (1990). Improved compliance measures: Applications in an ambulatory hypertensive drug trial. Clinical Pharmacology and Therapeutics, 48, 676–685.CrossRefPubMed
go back to reference Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37, 1112–1118. doi:10.1086/378301.CrossRefPubMed Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37, 1112–1118. doi:10.​1086/​378301.CrossRefPubMed
go back to reference Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245. doi:10.1007/s10461-006-9078-6.CrossRefPubMed Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245. doi:10.​1007/​s10461-006-9078-6.CrossRefPubMed
go back to reference Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4 + cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, 810–816.PubMed Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4 + cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, 810–816.PubMed
Metadata
Title
Lack of Association between Retrospectively Collected Pharmacy Refill Data and Electronic Drug Monitoring of Antiretroviral Adherence
Authors
Trisha Acri
Thomas R. TenHave
Jennifer C. Chapman
Hillary R. Bogner
Robert Gross
Publication date
01-08-2010
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-008-9502-1

Other articles of this Issue 4/2010

AIDS and Behavior 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.